Blood Pressure Monitoring Devices Market Top Companies Analysis To Grow Your Business in 2022

Blood pressure is considered as one of the main risk factors for chronic heart disease. Advanced blood pressure monitoringdevices are used for regular remote monitoring and transmission of the blood pressure data to the physicians. Factors such as increase in geriatric population, rise in inclination towards home monitoring, and upsurge in incidence rate of chronic diseases, such as cardiovascular disorders and obesity, are expected to drive the market. Moreover, innovations in blood pressure monitoring devices, (such as introduction of digital blood pressure monitors) and rise in awareness among patients regarding advanced devices are expected to fuel the market growth. However, lack of awareness about these devices in low- and middle-income economies hampers the market growth.

The global blood pressure monitoring devices market was valued at $1,981 million in 2015, and is estimated to reach $2,926 million by 2022, registering a CAGR of 5.7% from 2016 to 2022. Digital blood pressure monitoring devices segment held around two-fifths share of the total market in 2015.

Download Report Sample @ https://www.alliedmarketresearch.com/request-sample/2166

Digital blood pressure monitoring devices segment is anticipated to dominate the global blood pressure monitoring devices market owing to the increase in the global incidence of hypertension. However, ambulatory blood pressure monitors segment is projected to be the fastest growing segment, as a result of increase in the outpatient cases and reimbursement support from the government.

Digital BP monitors at hospitals & clinics segment is expected to dominate the global blood pressure monitoring devices market, as these devices facilitate easy and early detection of a patients deteriorating health condition, thereby, enabling speedy intervention and diagnosis of diseases. However, the ambulatory BP monitoring devices at ambulatory surgical centers (ASCs) market is projected to be the fastest growing segment, owing to increase in the number of outpatient cases.

Inquire before buying @  https://www.alliedmarketresearch.com/purchase-enquiry/2166

North America was the highest revenue contributor to the global revenue in 2015, accounting for about two-fifths share, and is expected to maintain this trend. This is attributed to the increase in prevalence of hypertension, growth in awareness among patients about cost-effective blood pressure monitoring devices, and availability of advanced healthcare facilities in North American countries. However, Asia-Pacific is expected to grow at the highest rate, owing to its high population base, incomes, and improvement in patient awareness about advanced blood pressure monitoring devices.

The Major Key Players Are:

·        A&D Company, Limited

·        Contec Medical Systems Co., Ltd.

·        General Electric Company

·        Halma plc

·        Hill-Rom Holdings, Inc.

·        Koninklijke Philips N.V.

·        Masimo Corporation

·        Nihon Kohden Corporation

·        Omron Corporation

·        Smiths Group Plc.

Diabetic Retinopathy Market Size Prognosticated to Perceive a Thriving Growth by 2022

Diabetic retinopathy (DR) is a medical condition of the eye prevalent in diabetic individuals. It is mainly caused due to damage of the blood vessels of the retina. Without timely treatment, the disease leads to bleeding in the eyes, cloudy vision, and may even destroy the retina. DR is amongst the common cause of loss of vision in the diabetic population. From 1990 to 2010, DR holds the fifth position among the most common causes of preventable blindness and severe visual impairment.

The diabetic retinopathy market was valued at $966 million in 2015, and is projected to reach $2,490 million by 2022, growing at a CAGR of 14.4% from 2016 to 2022. The proliferative diabetic retinopathy segment accounted for more than half of the total market in 2015.

Download Report Sample @ https://www.alliedmarketresearch.com/request-sample/2010

The market is expected to witness significant growth during the forecast period due to factors such as increase in prevalence of diabetes, growth in geriatric population, rise in incidence of blindness due to diabetes, and augment in focus on awareness, which facilitates early diagnosis to control the diseases. Although these factors garner the growth of the market, dearth of skilled ophthalmologists and extended approval time for drugs can pose as a major obstacle for the growth of the diabetic retinopathy market. On the other hand, emergence of combined therapies for treatment of diabetic macular edema, and the emerging markets of the Asia-Pacific and LAMEA regions are anticipated to provide several opportunities for the market growth.

Proliferative diabetic retinopathy segment accounted for a major market share (more than half) in 2015 as the disease is one of the leading causes of blindness in diabetic patients. Moreover, nearly 20% of the people suffering from diabetic retinopathy (any type) have proliferative diabetic retinopathy.

North America accounted for majority of the share (nearly two-fifths) in the market in 2015, and is expected to remain dominant throughout the forecast period. This is attributed to the increase in incidence of diabetes along with the rise in geriatric population, increased patient awareness about diabetic retinopathy, and favorable reimbursement framework for retinopathy procedures. In addition, presence of highly sophisticated healthcare infrastructure is anticipated to provide new growth opportunities for the key players in this market.

Inquire before buying @ https://www.alliedmarketresearch.com/purchase-enquiry/2010

The major companies profiled Are:

Abbott Laboratories, Alimera Science, Allergan plc, Ampio Pharmaceuticals., Bayer AG, F. Hoffmann-La Roche, Novartis International AG, Pfizer, Regeneron Pharmaceuticals Inc., and Valeant Pharmaceutical.

The Other key players Are:

Boehringer Ingelheim GmbH, KOWA Company, Ltd., BCN Peptides S.A., and ThromboGenics NV.

Motion Preservation Devices Market Trends Estimates High Demand by 2022

The motion preservation devices market was valued at $920 million in 2015, and is projected to reach $1,902 million by 2022, registering a CAGR of 10.9% from 2016 to 2022, According to a new report published by Allied Market Research

Motion preservation devices are used to treat disorders associated with the spine. These devices are used to restore and maintain the normal alignment of the spine. The advent of minimally invasive spine surgery techniques and rise in incidence of spinal disorders drive the market. In addition, rise in geriatric population and technological developments in bone grafting products are anticipated to boost the demand for motion preservation devices, globally. However, unfavorable reimbursement scenario and stringent regulatory approval process hamper the market growth.

Download Free Report Sample @ https://www.alliedmarketresearch.com/request-sample/1954

Artificial disc replacement segment generated the highest revenue in the global non-fusion/motion preservation devices market in 2015, owing to their increased preference over spinal fusion procedures. In addition, the nuclear disc prostheses segment is anticipated to grow rapidly, registering a CAGR of 11.1% during the forecast period.

The global motion preservation devices market is segmented on the basis of surgery into open spine surgery and minimally invasive spine surgery (MISS). The open spine surgery segment generated the highest revenue in 2015. However, the MISS segment is expected to grow at the highest CAGR during the study period.

North America accounted for the majority of revenue in 2015, and is expected to maintain its dominance throughout the forecast period. This is attributed to increased adoption of motion preservation devices in surgery and rise in incidence of spinal disorders and impairments, such as spinal stenosis. However, the Asia-Pacific region is projected to grow rapidly during the forecast period, registering a CAGR of 11.5%. Improving healthcare infrastructures and increase in expenditures in the emerging markets, such as India and China, to cater to the unmet medical needs in these countries have bolstered the market growth.

The key players in the motion preservation devices market have focused on expanding their business operations in the fast-growing emerging countries by adopting the new product launch strategy.

The major companies profiled Are:

• Aurora Spine Corporation
• B. Braun Melsungen AG
• Depuy Synthes (Johnson & Johnson)
• Globus Medical, Inc.
• HPI Implants
• Paradigm Spine
• RTI Surgical, Inc.
• Raymedica, Inc.
• Spinal Kinetics, Inc.
• Ulrich GmbH & Co. KG
• Zimmer Biomet Holdings, Inc.

Get a purchase Enquiry @ https://www.alliedmarketresearch.com/purchase-enquiry/1954

Key findings of Motion Preservation Market:

• The artificial disc replacement devices segment accounted for nearly half of the global motion preservation devices market in 2015.
• The nuclear disc prosthesis device segment is the fastest growing segment and is poised to grow at a CAGR of 11.1% during the forecast period.
• The dynamic stabilization devices segment is expected to grow at a significant CAGR of 10.9%, owing to the use of flexible materials during dynamic stabilization procedure for restoring mobility in the spine.
• France and Germany jointly accounted for more than one-third share of the global motion preservation devices market in 2015.
• Japan was the major shareholder in the Asia-Pacific motion preservation devices market, accounting for more than one-third share in 2015.

Similar Report:

Transcriptomics Market

Antidepressant Drugs Market

Cytogenetics Market

Anticoagulants Market

About Us:

Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.

Allied Market Research provides one stop solution from the beginning of data collection to investment advice. The analysts at Allied Market Research dig out factors that help clients to understand the significance and impact of market dynamics. The company amplies client’s insight on the factors, such as strategies, future estimations, growth or fall forecasting, opportunity analysis, and consumer surveys among others. As follows, the company offers consistent business intelligent support to aid the clients to turn into prominent business firm.

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com
Market Pulse: https://blog.alliedmarketresearch.com
Follow Us on LinkedIn: https://www.linkedin.com/company/allied-market-research

Liquid Biopsy Market Growth Prospect and Future Scenario by Key Players 2023

The global liquid biopsy market accounted for $634 million in 2016, and is estimated to reach at $3,805 million by 2023, registering a CAGR of 28.9% from 2017 to 2023. North America was the highest contributor in the liquid biopsy market in 2016; however, Asia-Pacific is anticipated to witness a highest growth rate throughout the forecast period.

Liquid biopsy tests prove to be an easy and non-invasive method to access to molecular information about the tumor genome. Moreover, these tests facilitate early detection of cancer recurrence and characterization of tumor dynamics. Safety and efficiency of cancer treatment is improved by the use of these tests, owing to their ability to characterize new lesions, implement apt therapeutic targets, and predict the treatment outcome.

Download Free Report Sample @ https://www.alliedmarketresearch.com/request-sample/1891

The advantages of implementing liquid biopsy over conventional methods of solid tissue biopsy are expected to boost the growth of the market. The advantages of liquid biopsies, such as minimally invasiveness and metastatic relapse evaluation, are expected to increase the demand for these tests. Furthermore, the increase in disposable income among cancer patients, surge in prevalence of cancer cases, and patient preference for minimally invasive therapies are anticipated to fuel the market growth. Rise in healthcare expenditure in the developing countries, such as India and China, and use of liquid biopsy tests to treat rare cancers are expected to present multiple opportunities for market growth. However, this growth is restricted, owing to alternatives to liquid biopsies and unclear reimbursement & regulation scenario.

Reagent was the highest revenue contributor in 2016, and is anticipated to continue this trend in the future. The requirement of reagents to execute liquid biopsy tests and their applicability are expected to boost the growth of this segment.

Lung cancer dominates the cancer by type segment of liquid biopsy market. The U.S. Food and Drug Administration (FDA) has also approved a liquid biopsy companion diagnostic test called cobas EGFR mutation test v2 to identify patients with metastatic non-small cell lung cancer (NSCLC) In addition, the growth in prevalence of lung cancer has contributed to provide lucrative opportunities in the market.

In 2016, North America accounted for highest contribution to the total revenue generated, owing to the high prevalence rate of cancer and high adoption rate of novel liquid biopsy tests. However, Asia-Pacific is expected to witness the highest CAGR during the analysis period, attributable to rise in disposable income, increase in government initiatives to modernize healthcare infrastructure, and rise in healthcare expenditure.

The Major key companies profiled Are:

• Biocept, Inc.
• Qiagen
• F. Hoffmann-La Roche AG
• Bio-Rad Laboratories Inc.
• Myriad Genetics
• Janssen Diagnostics, LLC.
• Trovagene Inc.
• Guardant Health Inc.
• GRAIL
• MDX Health SA.

Get a purchase Enquiry @ https://www.alliedmarketresearch.com/purchase-enquiry/1891

Key Findings of the Liquid Biopsy Market:

• The government & academic research center segment is projected to grow at the highest rate during the analysis period.
• Hospital & laboratory segment was the highest revenue-generating segment, and is expected to continue its dominance in future.
• North America dominated global liquid biopsy market, and is projected to grow at a CAGR of 28.1%.
• China is expected to grow at the highest CAGR of 34.1% in Asia-Pacific region.
• The instruments segment is anticipated to grow at the highest CAGR of 29.8% during the forecast period.

Similar Reports:

Autotransfusion Devices and Consumables Market

Vital Organs Support Systems and Medical Bionics Market

Preoperative Surgical Planning Software Market

Osseointegration Implants Market

About Us:

Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.

Allied Market Research provides one stop solution from the beginning of data collection to investment advice. The analysts at Allied Market Research dig out factors that help clients to understand the significance and impact of market dynamics. The company amplies client’s insight on the factors, such as strategies, future estimations, growth or fall forecasting, opportunity analysis, and consumer surveys among others. As follows, the company offers consistent business intelligent support to aid the clients to turn into prominent business firm.

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com
Market Pulse: https://blog.alliedmarketresearch.com
Follow Us on LinkedIn: https://www.linkedin.com/company/allied-market-research

Dental Implants and Prosthetics Market to Perceive Substantial Growth During by 2023

The global dental implants and prosthetics market was valued at $7,031 million in 2016, and is projected to reach $12,743 million by 2023, registering a CAGR of 8.8% from 2017 to 2023. The dental implants segment dominated the global market, accounting for more than half share of the total market in 2016.

A dental implant is a medical device used as a frame for surgical procedures to connect a dental prosthetic, such as crown, bridge, denture, and facial prosthesis to the jaw or skull bone. These implants are artificial tooth roots implanted into the gums/jaws, which are not visible post the surgical procedure.

Download Free Report Sample @ https://www.alliedmarketresearch.com/request-sample/1068

Rise in incidence of dental caries and periodontal conditions is expected to drive the dental implants and prosthetics market during the forecast period. Furthermore, increase in incidence of complete and partial edentulism, growth in elderly population, which is highly prone to tooth loss, surge in awareness, demand for tooth restorative technologies, and focus on quality dental care are expected to boost the market growth. However, limited dental insurance and reimbursement rates hamper the growth of global dental implants and prosthetics market.

The root-form dental implant segment accounted for the major share in the dental implants and prosthetics market and is expected to continue its dominance throughout the forecast period. This segment is expected to grow at a CAGR of 6.1% from 2017 to 2023, owing to high prevalence of dental caries and periodontal procedures.

In 2016, Europe accounted for nearly two-fifths of the global market, owing to the high prevalence of dental caries. North America holds the second position in the global dental implants and prosthetics market.

The major companies profiled in the report includes:

• Institut Straumann AG
• Danaher Corporation
• Dentsply Sirona Inc.
• 3M Company
• Zimmer Biomet Holdings, Inc.
• Avinent Implant System
• S.L.
• CAMLOG Biotechnologies AG
• BioHorizons IPH, Inc.
• Osstem Implant Co., Ltd.
• Bicon, LLC.

Inquiry Before Buying @ https://www.alliedmarketresearch.com/purchase-enquiry/1068

Key Findings of the Dental Implants and Prosthetics Market:

• The plate-form dental implants segment is projected to grow at CAGR of 7.3% during the forecast period.
• Europe accounted for a dominant position in the regional landscape in 2016, occupying a share of more than two-fifths of the total market.
• In 2016, the dental implants segment accounted for a share of more than half of the total dental implants and prosthetics market.
• The metals segment accounted for a share of more than half of the global dental implants and prosthetics market, by material in 2016.

Similar Reports:

Ophthalmic Lasers Market

Diabetic Retinopathy Market

Spinal Fusion Devices Market

Spine Biologics Market

About Us:

Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.

Allied Market Research provides one stop solution from the beginning of data collection to investment advice. The analysts at Allied Market Research dig out factors that help clients to understand the significance and impact of market dynamics. The company amplies client’s insight on the factors, such as strategies, future estimations, growth or fall forecasting, opportunity analysis, and consumer surveys among others. As follows, the company offers consistent business intelligent support to aid the clients to turn into prominent business firm.

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com
Market Pulse: https://blog.alliedmarketresearch.com
Follow Us on LinkedIn: https://www.linkedin.com/company/allied-market-research

Biosurgery Market Information Procurement and Data Analysis by 2022

The global biosurgery market is expected to garner $12,758.1 million by 2022, registering a CAGR of 8.1% during the period 2014 - 2022. Hemostatic and surgical sealing agents segment collectively held about half of the market share in 2015, which is expected to flourish over the forecast period. The neuro and spine surgery application segment is likely to lead the biosurgery market throughout the study period.

The biosurgery market is projected to grow at a substantial rate owing to rise in sport & spine-related injuries, per capita healthcare expenditure, rise in the number of surgeries due to increase in obese population along with lifestyle disorders and others. Also, availability of multi-functional products would provide a lucrative market opportunity; for instance, apart from fibrins use as surgical sealants, it is also used as hemostatic agents to prevent excessive blood loss during cardiothoracic and orthopedic surgeries. However, factors that would hamper the market growth are high cost associated with surgeries, stern regulatory environment for product approval, and growing popularity of minimally invasive surgeries.

Do Enquiry for Sample Report @ https://www.alliedmarketresearch.com/request-sample/1235

The bone graft substitutes segment contributed to one-third share in the overall biosurgery market in 2015. This segment covers products such as cell-based matrices, bone morphogenetic proteins, demineralized bone matrix, and synthetic graft extenders. However, surgical sealant agents segment is expected to grow at the highest growth rate during the forecast period because of the availability of multifunctional products. The neuro- and spine surgery application segment is projected to dominate the market due to high penetration of bone graft substitute products usage in the surgeries. Also, current biologics products are more popular compared to synthetic biosurgical products, and this trend is expected to continue during the analysis period.

The Major key companies profiled Are:

• Medtronic PLC
• Baxter International Inc.
• C. R. Bard Inc.
• Johnson and Johnson
• Stryker Corporation
• Sanofi S.A.
• Atrium Medical Corporation (Maquet Getinge Group)
• Hemostasis LLC
• CryoLife Inc.
• Kuros Bioscience.

Get a purchase Enquiry @ https://www.alliedmarketresearch.com/purchase-enquiry/1235

Key findings of Biosurgery Market:

• Surgical sealants are projected to be the fastest growing segment in the biosurgery market with a CAGR of 10.7% from 2015 to 2022.
• Hemostatic agents segment is expected to overtake the bone graft substitute segment, and reach $4.3 billion by 2022.
• Neuro- and spine surgery application segment is projected to dominate this market throughout the forecast period.
• Biologic biosurgical products segment would continue to lead the biosurgery market with about three fourth of the market share in 2015.
• Asia-Pacific is projected to be the fastest growing biosurgery market with a CAGR of 10.7% from 2015 to 2022.

Similar Reports:

Cytogenetics Market

Anticoagulants Market

Empty Capsules Market

IVF Devices and Consumables Market

About Us:

Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.

Allied Market Research provides one stop solution from the beginning of data collection to investment advice. The analysts at Allied Market Research dig out factors that help clients to understand the significance and impact of market dynamics. The company amplies client’s insight on the factors, such as strategies, future estimations, growth or fall forecasting, opportunity analysis, and consumer surveys among others. As follows, the company offers 

consistent business intelligent support to aid the clients to turn into prominent business firm.

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1⟨855⟩550-5975
help@alliedmarketresearch.com 
Web: www.alliedmarketresearch.com

Congestive Heart Failure (CHF) Treatment Devices Market To Receive Overwhelming Hike In Revenues By 2022

Global Congestive Heart Failure (CHF) Treatment Devices Market would reach $14.8 billion by 2022, at a CAGR of 5.5% from 2016 to 2022, according to a new report published by Allied Market Research.Implantable cardioverter-defibrillator (ICDs) segment is expected to dominate the global CHF treatment devices market throughout the forecast period. North America is projected to continue its lead in terms of revenue, accounting for more than two-fifths share of the CHF treatment devices.

The major factors boosting the market growth include the growing incidence of heart failures, technological advancements in CHF treatment devices, and increasing adoption rates for these devices. In addition, rising incidence of diabetes, atherosclerosis, strokes, hypertension, and others due to faulty lifestyle habits such as unhealthy dietary habits, lack of physical activity, and smoking, among others are the leading causes of congestive heart failure.

Do Enquiry for Sample Report @ https://www.alliedmarketresearch.com/request-sample/663

Rising geriatric population base is expected to fuel the prevalence of congestive heart failures thereby augmenting the market growth. Presence of huge unmet medical needs and rising emphasis on early intervention and primary prevention of heart failures are also anticipated to drive the demand for these devices. However, high cost of these devices and unfavorable reimbursement scenario in the emerging countries are some of the factors that restrict the market growth.

Geographically, North America accounted for the majority of the share in the CHF treatment devices market in 2015, and is expected to maintain this lead throughout the forecast period. This was mainly attributed to the increasing incidence of heart failures, presence of highly sophisticated healthcare infrastructure, and adoption of advanced CHF treatment devices in the North American countries. However, Asia-Pacific is expected to be the fastest growing region throughout the analysis period, owing to ample growth opportunities in terms of unmet medical needs for the treatment of cardiac disorders in these regions.

The Major key players Are:

• Abiomed, Inc.
• Berlin Heart GmbH
• Biotronik SE & Co. KG
• Boston Scientific Corporation
• HeartWare International, Inc.
• Jarvik Heart, Inc.
• LivaNova PLC
• Medtronic plc
• ReliantHeart Inc.
• Jude Medical, Inc.

Get a purchase Enquiry @ https://www.alliedmarketresearch.com/purchase-enquiry/663

Key Findings of the CHF Market:

• In 2015, ICDs accounted for almost one-third of the overall market revenue, and is projected to grow at a CAGR of 4.8% during the forecast period.
• The VADs segment is likely to grow at a remarkable CAGR of 11.9%, owing to the innovation and miniaturization of devices.
• North America accounted for over 40% share of the global CHF treatment devices market in 2015.
• The U.S. is projected to maintain its lead in the CHF treatment devices market until 2022.
• China and Japan are the major shareholders in the Asia-Pacific region, jointly accounting for almost half of share in the Asia-Pacific market.

Similar Reports:

India Disposable Gloves Market

ASEAN Blood Pressure Monitoring Devices Market

North America Medical Tourism Market

Companion Diagnostic Market

About Us:

Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.

Allied Market Research provides one stop solution from the beginning of data collection to investment advice. The analysts at Allied Market Research dig out factors that help clients to understand the significance and impact of market dynamics. The company amplies client’s insight on the factors, such as strategies, future estimations, growth or fall forecasting, opportunity analysis, and consumer surveys among others. As follows, the company offers consistent business intelligent support to aid the clients to turn into prominent business firm.

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com
Market Pulse: https://blog.alliedmarketresearch.com
Follow Us on LinkedIn: https://www.linkedin.com/company/allied-market-research